Conditional risk factors for atherosclerosis

Iftikhar Jan Kullo, Christie M. Ballantyne

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating biomarkers related to the atherosclerotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently available to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.

Original languageEnglish (US)
Pages (from-to)219-230
Number of pages12
JournalMayo Clinic Proceedings
Volume80
Issue number2
StatePublished - 2005

Fingerprint

Atherosclerosis
Coronary Disease
Biomarkers
Lipoprotein(a)
Homocysteine
LDL Lipoproteins
Particle Size
C-Reactive Protein
Fibrinogen

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Conditional risk factors for atherosclerosis. / Kullo, Iftikhar Jan; Ballantyne, Christie M.

In: Mayo Clinic Proceedings, Vol. 80, No. 2, 2005, p. 219-230.

Research output: Contribution to journalArticle

Kullo, IJ & Ballantyne, CM 2005, 'Conditional risk factors for atherosclerosis', Mayo Clinic Proceedings, vol. 80, no. 2, pp. 219-230.
Kullo, Iftikhar Jan ; Ballantyne, Christie M. / Conditional risk factors for atherosclerosis. In: Mayo Clinic Proceedings. 2005 ; Vol. 80, No. 2. pp. 219-230.
@article{9f0035315e1e40dca967b3761e9e26ef,
title = "Conditional risk factors for atherosclerosis",
abstract = "Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating biomarkers related to the atherosclerotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently available to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.",
author = "Kullo, {Iftikhar Jan} and Ballantyne, {Christie M.}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "219--230",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "2",

}

TY - JOUR

T1 - Conditional risk factors for atherosclerosis

AU - Kullo, Iftikhar Jan

AU - Ballantyne, Christie M.

PY - 2005

Y1 - 2005

N2 - Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating biomarkers related to the atherosclerotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently available to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.

AB - Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating biomarkers related to the atherosclerotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently available to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.

UR - http://www.scopus.com/inward/record.url?scp=13344276503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13344276503&partnerID=8YFLogxK

M3 - Article

C2 - 15704777

AN - SCOPUS:13344276503

VL - 80

SP - 219

EP - 230

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 2

ER -